SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 22, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago
Insider cluster: 5 insiders, $0.4M total
Actionable Insight • Neutral

The C-suite cluster sale is not a bearish signal given the trivial dollar amount relative to market cap and the simultaneous timing across all four executives. This pattern is consistent with a routine 10b5-1 plan or post-blackout-window opening. Monitor the next 8-K or earnings release for any material business update that could have prompted the sales, but the current data does not suggest a negative read-through.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$83.40
T+0 close · Jun 22, 2026 · via day close
Latest settled
+12.17%
T+60 · $93.55
Vs SPY
+9.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 23 $83.40entry
  2. T+1 · 5mo ago −1.57%α −1.52% · $82.09
  3. T+5 · 5mo ago +10.90%α +9.89% · $92.49
  4. T+20 · 4mo ago +9.96%α +8.80% · $91.71
  5. T+60 · 2mo ago +12.17%α +9.38% · $93.55
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five Oruka Therapeutics insiders, including the CEO, CMO, COO, General Counsel, and SVP Finance, sold a total of $396K in open-market shares over a 7-day window. The CEO sold $120K at $69.69, the CMO sold $112K at $68.38, and the COO sold $42K at $69.69. The cluster is notable for involving the entire C-suite (CEO, CMO, COO) plus the General Counsel and finance head, but the total dollar value is only ~0.009% of the $4.4B market cap, well below the 0.1% threshold for materiality. The sales appear to be routine, likely driven by shared blackout-window opening or 10b5-1 plan timing, not a coordinated bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$396.0K
Insiders
5

Key Facts

  • Five insiders sold open-market shares totaling $396K from June 15-22, 2026
  • CEO Paul Klein sold 1,700 shares at $69.69 for $120K
  • CMO Joana Goncalves sold 1,600 shares at $68.38 for $112K
  • COO Laura Lee Sandler sold 600 shares at $69.69 for $42K
  • General Counsel Paul Quinlan sold 733 shares at $69.69 for $51K
  • SVP Finance Arjun Agarwal sold 888 shares at $80.01 for $71K on June 22
  • Total sales represent ~0.009% of the $4.4B market cap, trivial in proportion
  • All C-suite sales occurred on the same date (June 15), suggesting a shared blackout-window or 10b5-1 plan opening

Financial Impact

Total insider sales of $396K, or ~0.009% of market cap, immaterial

dilution

Risk Factors

  • Insider sales at this scale are not predictive of stock movement; the cluster is noise
  • The stock has a 95% analyst buy rating and strong institutional backing (Fidelity, BlackRock, RTW), the selling is not aligned with the Street's bullish view

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1782172805450

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 9h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026